Suzhou Raycan Technology Co.

What Suzhou Raycan Technology Co. does

Suzhou Raycan Technology Co. is a privately held Chinese instrumentation company headquartered in Suzhou High-Tech Zone, Jiangsu Province, specializing in particle detection and medical imaging systems built around a proprietary scintillation pulse digitization method described as globally leading. The company sells two primary product families: the Trans-PET line of high-performance full-digital animal PET/CT systems (Discoverist 180, Discoverist 80, and Explorist 180) for preclinical and academic research, and the RadSys 2.0 digital radiation monitoring ecosystem, which integrates fixed environmental monitors (RadWall), personal dosimeters (RadTarge), hand/foot contamination detectors (RadHFC), and mobile inspection units (RadPavise) under a unified management software. Supporting these hardware systems are the RayPNI (Plug-n-Image) deployment platform and the RayPlus cloud-native medical imaging platform, which together provide plug-and-play imaging, AI-assisted analysis, and algorithm deployment capabilities.

The company's revenue model is anchored by high-value capital equipment sales to institutional buyers, supplemented by software licensing and integration services. Solution offerings span complete PET/CT radiation monitoring, accelerator center monitoring, and ECT radiation monitoring deployments, with pricing not publicly disclosed. Customer segments are primarily academic and preclinical research institutions, hospitals and nuclear medicine departments, and industrial and scientific research facilities, with named customers including Wuhan Tongji Hospital and Huazhong University of Science and Technology. Go-to-market is predominantly direct enterprise field sales in China with international distribution partners supporting overseas markets, augmented by academic publication-based credibility building and industry event participation. The company received WIPO Global Award recognition in 2022 as one of five global award recipients.

Name

Suzhou Raycan Technology Co.

Legal name

Suzhou Raycan Technology Co.

Website

https://ray-can.com

Company type

Private

Founded year

2009

Operating status

Operating

Headcount range

11–50 employees

Short description

Suzhou Raycan Technology Co. is a privately held Suzhou-based instrumentation company that designs and sells full-digital preclinical PET/CT systems, digital radiation monitoring ecosystems, and particle detectors, serving academic research institutions, hospitals, and nuclear medicine departments worldwide.

Ownership category

akta.pro rank

Product category

Medical Imaging Equipment

NAICS

Irradiation Apparatus Manufacturing (334517), In-Vitro Diagnostic Substance Manufacturing (325413)

SIC

Surgical & Medical Instruments & Apparatus (3841), Industrial Instruments For Measurement, Display, And Control (3823), X-Ray Apparatus & Tubes & Related Irradiation Apparatus (3844)

akta.pro primary industry

Nuclear Medicine & Molecular Imaging (SPECT/PET) (HLAHABAE)

akta.pro secondary industries

Computed Tomography (CT) Systems (HLAHABAB), X-ray & Fluoroscopy Systems (HLAHABAA), Nuclear Medicine Imaging Tracers & PET/SPECT Supply Chain (FDG, Ga-68, logistics/cold chain) (EUAKAIAE), Advanced Imaging & Specialty Radiology Centers (PET/CT, Nuclear Medicine, Interventional Radiology) (HLAFAKAB)

Keywords

• Radiation detection systems
• PET imaging systems
• Particle detectors
• Radiation monitoring
• Scintillation digitization

Headquarters

HQ city

Suzhou

HQ country

China

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Personnel, Supply Chain, Operations, Marketing or Sales

Revenue model

1. Medical Imaging Systems Sales: Sale of high-value animal PET/CT imaging systems including Trans-PET Discoverist 180, Trans-PET Discoverist 80, and Trans-PET Explorist 180 for preclinical research, drug development, and academic research institutions
2. Radiation Detection Hardware: Sale of particle detectors and radiation monitoring equipment including BDM (Basic Detector Module), RadWall, RadTarge, RadHFC, RadPavise products for environmental monitoring, personal dosimetry, and contamination detection
3. Software Platforms (RayPNI, RayPlus): Licensing and deployment of intelligent imaging software platforms for medical imaging data processing, analysis and cloud-based visualization
4. Solutions and Integration Services: Complete solutions for PET/CT radiation monitoring, accelerator center monitoring, and ECT radiation monitoring including site layout planning and workstation configuration

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Suzhou Raycan Technology Co. develops and manufactures particle detection and medical imaging systems built on a proprietary scintillation pulse digitization method. Its product portfolio includes high-performance all-digital animal PET/CT systems (Trans-PET series), a fully digital radiation monitoring ecosystem (RadSys 2.0 with RadWall, RadTarge, RadHFC, RadPavise), basic particle detector modules, and intelligent imaging software platforms (RayPNI/Plug-n-Image and RayPlus cloud platform).

Product overview

Suzhou Raycan Technology Co. offers a comprehensive portfolio of particle detection and medical imaging products built around their globally leading scintillation pulse digitization technology. The portfolio consists of two main product lines: (1) Trans-PET animal full-digital PET/CT systems (Discoverist 180, Discoverist 80, Explorist 180) for preclinical research applications including drug screening, oncology, cardiology, and neuroscience studies; and (2) RadSys 2.0 fully digital radiation monitoring systems comprising RadTarge personal dosimeters, RadWall environmental monitors, RadHFC contamination detectors, and RadPavise mobile inspection devices. Supporting these hardware systems are RayPNI (Plug-n-Image) software platform for intelligent imaging deployment and RayPlus cloud platform for medical image management and AI analysis.

Differentiator

Problem solved

Functional benefit

Brands

• RadTarge: Personal dosimeter product line including RadTarge and RadTarge-Mini models
• RadWall
• RadHFC
• RadSys
• Trans-PET
• BDM (Basic Detector Module)
• PNI (Plug-n-Image)
• RayPlus
• RadPavise

Products and services

• Trans-PET Discoverist 180

Quantifiable outcome

• 20cm × 16cm AFOV × TFOV field of view for large animal coverage
• +4 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators2 records

Recent moves5 records

Expansion highlights6 records

Broad incumbents

• Landauer (Fortive): Landauer is a global leader in personal dosimetry and environmental radiation monitoring, serving hospitals, research institutions, and nuclear facilities — directly comparable to Raycan's RadTarge personal dosimeter and RadWall environmental monitoring products.
• GE HealthCare: GE HealthCare is a major PET/CT and medical imaging incumbent with global clinical and preclinical presence, competing broadly with Raycan's imaging technology across both research and clinical nuclear medicine segments.
• Siemens Healthineers: Siemens Healthineers is a dominant clinical PET/CT and molecular imaging incumbent whose broader portfolio and R&D resources establish the competitive benchmark that Raycan's preclinical PET systems must differentiate against.
• Thermo Fisher Scientific: Thermo Fisher provides radiation detection and monitoring instruments alongside a broad life sciences portfolio, overlapping with Raycan's particle detectors and radiation monitoring products through its Analytical Instruments segment.

Others

• Hamamatsu Photonics: Hamamatsu is a leading global supplier of scintillation detectors, photomultiplier tubes, and radiation detection components — a key enabling technology supplier and adjacent competitor to Raycan's scintillation-based particle detection platforms.

Emerging players

• Molecubes: Molecubes is a smaller, emerging player in benchtop preclinical PET and SPECT/CT systems, competing with Raycan in the same high-throughput preclinical imaging customer segment with modular, accessible price points.
• Berthold Technologies: Berthold Technologies specializes in radiation measurement and monitoring systems for nuclear medicine, research, and industrial use — overlapping with Raycan's RadSys 2.0 and particle detector product lines in environmental and laboratory radiation monitoring.

Direct peers

• Mirion Technologies: Mirion is a global leader in radiation monitoring and detection, competing directly with Raycan's RadSys 2.0, RadWall, RadTarge, and RadHFC product lines in nuclear medicine facilities, environmental monitoring, and personal dosimetry.
• Mediso Medical Imaging Systems: Mediso is a leading European manufacturer of preclinical PET/SPECT/CT systems (nanoScan), directly competing with Raycan's Trans-PET Discoverist and Explorist products in academic and translational research imaging.
• Bruker Corporation: Bruker's preclinical PET and PET/CT systems (e.g., Albira, MicroPET) directly compete with Raycan's Trans-PET line in the animal imaging market, serving the same academic and pharmaceutical research customers with molecular imaging platforms.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/raycan-technology-co-ltd

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Suzhou Raycan Technology Co.